Use of Pyrosequencing to detect clinically relevant polymorphisms of genes in basal cell carcinoma
- 25 February 2004
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 342 (1-2) , 137-143
- https://doi.org/10.1016/j.cccn.2003.12.010
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Croatian population data for the C677T polymorphism in methylenetetrahydrofolate reductase: frequencies in healthy and atherosclerotic study groupsClinica Chimica Acta; International Journal of Clinical Chemistry, 2003
- Cyclin D1 Genotype, Response to Biochemoprevention, and Progression Rate to Upper Aerodigestive Tract CancerJNCI Journal of the National Cancer Institute, 2003
- Impact of new mutations in the methylenetetrahydrofolate reductase gene assessed on biochemical phenotypes: A familial studyJournal of Inherited Metabolic Disease, 2001
- The role of cytokines in cancer-related fatigueCancer, 2001
- Overexpression of interleukin-6 in human basal cell carcinoma cell lines increases anti-apoptotic activity and tumorigenic potencyOncogene, 2001
- Conditions for Single-Strand Conformation Polymorphism (SSCP) Analysis of BRCA1 Gene Using an Automated Electrophoresis Unitcclm, 2001
- Multiplex SSCP and Heteroduplex Analysis with Southern Hybridization for Large-Scale Mutation DetectionGenomics, 1998
- A Sequencing Method Based on Real-Time PyrophosphateScience, 1998
- Germ line polymorphisms in cytochrome-P450 1A1 (C4887 CYP1A1) and methylenetetrahydrofolate reductase (MTHFR) genes and endometrial cancer susceptibilityCarcinogenesis: Integrative Cancer Research, 1997
- The expression of cytokines by an established basal cell carcinoma cell line (BCC-1/KMC) compared with cultured normal keratinocytesArchives of Dermatological Research, 1996